Background and Purpose-Studies have suggested that the early excess risk of stroke in coronary artery bypass grafting (CABG) may be compensated for by a slow but progressive catch-up phenomenon in patients undergoing percutaneous coronary intervention (PCI). We therefore undertook this analysis to compare the temporal stroke risk between PCI and CABG in patients with unprotected left main stenosis and multivessel coronary artery disease. Methods-Studies of PCI versus CABG for unprotected left main stenosis and multivessel disease published between January 1994 (stent era) and July 2013 were identified using an electronic search and reviewed using meta-analytic techniques. Results-We selected 57 reports for the meta-analysis by applying the inclusion and exclusion criteria. 
P ercutaneous coronary intervention (PCI) has been shown in several randomized controlled trials and meta-analyses to parallel coronary artery bypass grafting (CABG) for shortand long-term mortality in patients with complex coronary artery disease. [1] [2] [3] [4] [5] The focus in comparing the 2 strategies has therefore shifted from mortality to morbidity. Stroke is increasingly recognized as an important cause of morbidity that is more frequent after CABG. This was first recognized in the landmark Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial 3 and subsequently in meta-analyses comparing the 2 strategies at 30 days and 1 year. [6] [7] [8] However, of concern, more recently when patients in the SYNTAX trial were followed up for ≤5 years, the difference had narrowed (PCI versus CABG: 3.4% versus 2.4%; P=0.09), suggesting a catch up in the PCI arm, thus negating any benefit that was observed in the initial period. 9, 10 Importantly, the SYNTAX trial was underpowered to detect a difference in stroke rates. We therefore analyzed data from all comparative trials on PCI versus CABG to explore the late catch-up phenomenon of stroke in the PCI arm.
Study End Points
The primary end point was cumulative stroke at follow-up stratified by time points. Secondary end points were stroke within 30 days (early, within 24-48 hours of the procedure, and delayed, >48 hours but within 30 days) and late stroke (stroke occurring after 30 days).
Statistical Analysis
A forest plot with combined odds ratio (OR) estimates and 95% confidence intervals (CI) was constructed using the random effects model of Der Simonian and Laird. Statistical significance for OR was set at P<0.05 (2-tailed) provided the CI did not cross 1. Heterogeneity, which was anticipated to be significant, was assessed by a Q-statistic and I 2 test. Significant heterogeneity was considered present for P values <0.10 and an I 2 ≥50%. Sensitivity analysis was performed by performing a (1) fixed effects and random effects analysis and (2) conducting a subgroup analysis (multivessel disease, unprotected left main stenosis, diabetics, randomized controlled trials). Data analysis was performed using RevMan version 5.0. 13 Meta-regression analysis was performed on a priori selected variables (target vessel revascularization [TVR] and atrial fibrillation at follow-up) to identify risk factors for late stroke using Comprehensive Meta-analysis version 2.
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Results
Using the search key words, 23 054 reports were identified, of which 712 relevant publications were identified at the abstract and title levels. By applying the inclusion and exclusion criteria, 57 reports were selected for the meta-analysis ( Figure  I in the online-only Data Supplement). These included 9 randomized comparisons and 48 nonrandomized comparisons. All studies included in the analysis were published between 2001 and 2013. Analysis was performed on 80 314 patients, of whom 41 597 (51.8%) underwent PCI with stenting and 38 717 (48.2%) who underwent CABG. The study characteristics and overall patient demographics are shown in Tables  I and II in the online-only Data Supplement, respectively. The baseline characteristics of PCI and CABG arms of each included study are shown in Tables III and IV in the onlineonly Data Supplement, respectively. The time point analysis involved 35 studies (39 497 patients) on 1-year outcomes, 22 on 2-year outcomes (29 389 ), 17 on 3-year outcomes (40 584 patients), 9 on 4-year outcomes (21 960 patients), 13 on 5-year outcomes (22 518 patients), and 4 on >5 years (1676 patients).
There was a significant difference in the incidence of cumulative stroke ( There was no statistically significant difference (OR, 0.71; 95% CI, 0.46-1.08), despite an effect size in favor of PCI, in the incidence of cumulative stroke at >5 years between PCI and CABG.
We explored the robustness of our findings by performing subgroup analysis on PCI versus CABG for (1) multivessel disease, (2) unprotected left main disease, (3) diabetics, and (4) randomized controlled studies.
In patients undergoing PCI or CABG for multivessel disease, cumulative stroke was more common after CABG at 1 year (OR, 0.55; 95% CI, 0.41-0.74), at 2 years (OR, 0.77; 95% CI, 0.62-0.95), 3 years (OR, 0.77; 95% CI, 0.70-0.86), 4 years (OR, 0.72; 95% CI, 0.60-0.86), and 5 years (OR, 0.82; 95% CI, 0.72-0.95). There was no statistically significant difference in the incidence of cumulative stroke at >5 years (OR, 0.71; 95% CI, 0.45-1.14) between PCI and CABG ( Figure 2 ). There was, however, a trend in favor of PCI. Of note, there were only 1676 patients with follow-up >5 years.
Similarly, in the left main ( Figure 3 ) and diabetic subset (Figure 4 ), cumulative stroke occurred significantly less after PCI than CABG with a trend in favor of PCI when not statistically significant. Subgroup analysis of randomized controlled trials showed a lower incidence of cumulative stroke after PCI than CABG at 1 (OR, 0.50; 95% CI, 0.33-0.77) and 5 years (OR, 0.69; 95% CI, 0.52-0.93; Figure 5 ).
Stroke within 30 days (early and delayed stroke) occurred significantly less often after PCI than CABG (OR, 0.26; 95% CI, 0.20-0.35; Figure II in the online-only Data Supplement). The incidence of late stroke was similar in the 2 groups (Table) .
Meta-regression analysis showed no significant interaction between TVR after PCI and the summary log odds of stroke ( Figure III in the online-only Data Supplement). We could not assess the risk of postprocedural atrial fibrillation because of incomplete reporting by the primary studies.
Discussion
The main results of the current analysis on 80 314 patients are as follows: (1) patients with multivessel or unprotected left main coronary artery disease undergoing revascularization by guest on April 12, 2017 http://stroke.ahajournals.org/ Downloaded from have a significantly lower risk of cumulative stroke with PCI when compared with CABG (≤5 years). There is no late catchup phenomenon of stroke as seen in the SYNTAX trial. This conclusion is supported by subgroup analysis of randomized comparisons and comparisons on multivessel disease, unprotected left main disease, and diabetics. (2) Early and delayed stroke are significantly lower in patients undergoing PCI, and (3) late stroke is equally distributed between the 2 strategies during follow-up.
PCI with stenting or CABG has yielded comparable rates of short-and long-term mortality in treatment of multivessel coronary artery disease or unprotected left main. [1] [2] [3] [4] [5] The choice of one instead of the other has therefore depended on weighing the risk of stroke versus repeat revascularization. Repeat revascularization is uniformly high after PCI, whereas procedural stroke is common after CABG. [1] [2] [3] [4] [5] Stroke occurring after either revascularization strategy can also be delayed (within 30 days) or late (after 30 days) besides early procedural stroke (within 24-48 hours). In depth analysis of the SYNTAX trial has challenged the true risk benefit of PCI by suggesting an increase in late stroke in patients undergoing PCI.
9,10 At 5 years the occurrence of stroke was not statistically significant between the 2 groups (P=0.09) as opposed to 30 days (P=0.03). Similar trends have been observed by other investigators. In an individual patient data meta-analysis of 3051 patients from 4 randomized controlled trials, Daemen et al 4 reported a similar hazard ratio of cumulative stroke during a 5-year follow-up (hazard ratio,1.16; 95% CI, 0.73-1.83). The CREDO-Kyoto Investigators 15 found no difference in the occurrence of cumulative stroke after PCI or off pump CABG during a 3.4-year follow-up (4.93% versus 6.01%).
Of note, (1) stroke is an uncommon occurrence after either procedure, but with devastating outcomes, making it an important safety end point, and (2) the individual trials were not adequately powered to detect differences in stroke rates. We therefore undertook this meta-analysis to explore the risk of stroke during long-term follow-up.
We found an increased cumulative risk of stroke within a year among those who underwent CABG, a finding that was consistent with previous meta-analyses. [6] [7] [8] We also uncovered a persistent risk of cumulative stroke with CABG ≤5 years from the index procedure. This finding is important and reassuring in the background of concerns raised by the SYNTAX Investigators given that PCI is widely performed for multivessel coronary artery disease and unprotected left main. Unlike TVR, stroke is relatively less frequent but a major safety end point with significant mortality and morbidity. [16] [17] [18] In the SYNTAX trial, of the patients who had a stroke and survived, 68% of the CABG patients versus 47% of the PCI patients had residual deficits. 10 This suggests that in survivors of stroke after CABG, there is a higher likelihood of persistence of neurological deficits and increased morbidity. We could not investigate this in our analysis as the above data were unavailable in the primary studies. Nevertheless, the exceedingly high rates of disability and healthcare utilization associated with stroke after CABG should not be ignored or traded for the lower incidence of TVR after CABG.
The estimated incidence of early and delayed stroke is 2% to 9% after CABG 19 and 0.15% to 0.44% after PCI in the literature. 20 Considering the mechanisms by which stroke may occur, it is not surprising that the risk of early and delayed stroke is increased among those who undergo CABG. 6, 8 Age, hypertension, diabetes mellitus, chronic renal failure, low ejection fraction, peripheral vascular disease, aortic arch atherosclerosis, carotid artery disease, prior stroke history, and perioperative atrial fibrillation are common denominators pertaining to stroke risk from either strategy. [17] [18] [19] [20] Thrombo/ atheroembolism from aortic manipulation, intraoperative hypoperfusion, on pump procedures, duration of bypass, and requirement of blood transfusions are more specific to early stroke in patients undergoing CABG. 17, 19 With improvement in surgical techniques, the temporal profile of stroke reveals an increased incidence in postoperative day 2, implying that inflammation and hypercoagulability may play a greater role. 17 In patients with severe atherosclerosis of the cervical and cranial vessels, inflammation can trigger delayed plaque rupture or platelet aggregation with consequent embolism. 21, 22 Late stroke, however, seems to be equally distributed between the 2 strategies during follow-up. The reasons are unclear for late stroke after CABG or PCI added to traditional risk factors. Potential mechanisms may include atrial fibrillation, repeat revascularizations, and differences in pharmacotherapy. 10, 23 Post-CABG atrial fibrillation is common and occurs in 30% to 50% of patients. 24 Similarly, atrial fibrillation can occur after PCI, albeit at a lower risk. The reported incidence of atrial fibrillation after PCI varies between 6.2% and 8.0% in patients undergoing primary PCI for myocardial infarction. 25 The mechanisms for post-PCI atrial fibrillation are poorly understood. It is induced most commonly in response to catheter placement into or out of the right atrium and during balloon occlusion of the coronary vessels. 26 Atrial fibrillation has been found consistently to increase stroke rate in various clinical settings and is therefore likely an important mechanism of late stroke after either procedure. 27, 28 The risk of adverse cerebrovascular events with each repeat revascularization is likely additive. Interventions on the vein grafts have been shown to be predictive of post-PCI strokes. 29 Fuchs et al 29 in a retrospective analysis of 12 407 PCIs identified vein graft interventions as a risk factor for post-PCI stroke (OR, 2.7; 95% CI, 1.3-5.8). Interestingly, stenotic lesions (P=0.75) or number of lesions dilated (P=0.22) was not associated with an increased risk of stroke. Uniformly across all registries and randomized control trials, TVR has been shown to be higher in patients undergoing PCI. [1] [2] [3] [4] [5] This may lend to late strokes in patients undergoing PCI with stenting. We, however, found no interaction in our regression model for rates of TVR after PCI and summary odds of stroke. Also, note that despite the high TVR in the PCI arm, there was no late catch up of stroke ≤5 years. One year after CABG, 10% to 20% of saphenous vein grafts fail, an additional 5% to 10% fail between 1 and 5 years, and an additional 20% to 25% fail between 6 and 10 years. Beyond 5 years, the incidence of vein graft occlusions is therefore ≈25%. 30, 31 This has a potential to increase TVR in the CABG arm, with the possibility for increased stroke risk from vein graft interventions. The sample size in our analysis declined >5 years thereby affecting any meaningful comparison between the 2 strategies for that period. The use of second-generation drug-eluting stents was also negligible in the included studies. Second-generation drug-eluting stents have been shown to reduce TVR rates significantly in all lesions when compared with bare metal stents or first-generation drug-eluting stents. 32, 33 Adherence to optimal medical therapy may influence the occurrence of post-CABG cerebrovascular events. Recent analyses of data from a health plan database revealed that CABG patients were less likely to be on statins or angiotensin converting enzyme inhibitors, which in turn puts them at higher risk of cardiovascular events. 34 Patients in the CABG arm were more likely than patients in the PCI arm to not fill a prescription for a statin (7.1% versus 4.8%; P<0.00) or an angiotensin converting enzyme-I/angiotensin receptor blocker (29.1 versus 22.4; P<0.00). The use of statins has been shown to be associated with lower risk of postoperative stroke both in early 35 and late follow-up. 36 Dual antiplatelet therapy is also not routine after CABG. 10 This can again contribute to late strokes in patients undergoing CABG.
Limitations
We acknowledge several important limitations of this analysis. We were unable to investigate the benefits of off pump surgery because of the nature of our analysis. (6) We were unable to identify potential pathogenesis of late stroke. Meta-regression often fails to capture an interaction between summary treatment effect and patient level risk factors. Individual patient data analysis is necessary to identify any such interactions.
Nevertheless, compared with prior meta-analyses on this topic, our analysis is significantly larger (80 314) and provides the temporal stroke risk >1 year. Our analysis was performed on contemporary revascularization procedures unlike the prior analyses that included studies on balloon angioplasty. The results of this analysis are, therefore, more relevant to the current era and address the concerns (late catch up of stroke with PCI) raised by the SYNTAX trial.
Conclusions
There is a significantly lower risk of cumulative, early and delayed stroke with PCI as compared with CABG during a 5-year follow-up. The incidence of late stroke is similar between PCI and CABG. This suggests that a late catch-up phenomenon of stroke in the PCI arm is unlikely. On the contrary, there is a significant risk of stroke after CABG that must be weighed when deciding between revascularization strategies.
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